Inventor · disambiguated record
Che-Kun James Shen
Also filed as: SHEN CHE-KUN J · SHEN CHE-KUN JAMES
16 granted patents·8 pending applications·343 citations·filing 1976–2023
91Inventor score
Top patents by PatentIndex Score
24 records- 0198US4196281APsoralensUNIV CALIFORNIA·Filed 1978·Granted Apr 1, 1980·122 cites·12 claims
- 0298US4124598APsoralensHOFFMANN LA ROCHE·Filed 1976·Granted Nov 7, 1978·118 cites·5 claims
- 0397US4169204APsoralensUNIV CALIFORNIA·Filed 1978·Granted Sep 25, 1979·90 cites·7 claims
- 0478US9662324B2Methods and compositions for treating β-thalassemia and sickle cell diseaseACADEMIA SINICA·Filed 2014·Granted May 30, 2017·3 cites·16 claims
- 0574US9186356B2Methods for treating frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U)SHEN CHE-KUN JAMES·Filed 2012·Granted Nov 17, 2015·4 cites·7 claims
- 0673US11266697B2Methods for enhancing lifespan and/or treating cellular proliferative disorders by transplantationACADEMIA SINICA·Filed 2017·Granted Mar 8, 2022·1 cites·24 claims
- 0768US8822491B2Methods and compositions for treating β-thalassemia and sickle cell diseaseSHEN CHE-KUN JAMES·Filed 2012·Granted Sep 2, 2014·2 cites·20 claims
- 0863US2025276014A1Genetically engineered innate lymphoid cells for enhancing lifespan and/or treating cancersACADEMIA SINICA·Filed 2023·Application pending·0 cites
- 0962US11582957B2TDP-43 knock-in mouse model of amyotrophic lateral sclerosisACADEMIA SINICA·Filed 2019·Granted Feb 21, 2023·0 cites·20 claims
- 1061US11254719B2Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesisACADEMIA SINICA·Filed 2019·Granted Feb 22, 2022·0 cites·3 claims
- 1160US8476485B2Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 functionSHEN CHE-KUN JAMES·Filed 2011·Granted Jul 2, 2013·2 cites·20 claims
- 1260US2022143102A1Methods for enhancing lifespan and/or treating cellular proliferative disorders by transplantationACADEMIA SINICA·Filed 2022·Application pending·0 cites
- 1359US9770485B2Methods for rescuing learning and/or memory deficits caused by alzheimer's disease by G-CSFSHEN CHE-KUN JAMES·Filed 2009·Granted Sep 26, 2017·0 cites·15 claims
- 1456US6303845B1HS-40 enhancer-containing vectorACADEMIA SINICA·Filed 2000·Granted Oct 16, 2001·1 cites·14 claims
- 1556US2025099538A1Methods of treating neurodegenerative diseasesACADEMIA SINICA·Filed 2022·Application pending·0 cites
- 1655US9695463B2DNA 5-methyl cytosine demethylation activity of vertebrate DNA methyltransferasesACADEMIA SINICA·Filed 2013·Granted Jul 4, 2017·0 cites·20 claims
- 1755US2017290820A1Methods and compositions for treating beta-thalassemia and sickle cell diseaseACADEMIA SINICA·Filed 2017·Application pending·0 cites
- 1851US12246021B2Compounds for uses in pharmacological induction of HBF for treatment of sickle cell disease and ß-thalassemiaACADEMIA SINICA·Filed 2020·Granted Mar 11, 2025·0 cites·32 claims
- 1947US8324450B2Non-human animal model for frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U)SHEN CHE-KUN JAMES·Filed 2010·Granted Dec 4, 2012·0 cites·18 claims
- 2047US2002133838A1HS-40 enhancer-containing vectorFiled 2001·Application pending·0 cites
- 2144US10414809B2Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesisACADEMIA SINICA·Filed 2015·Granted Sep 17, 2019·0 cites·5 claims
- 2242US2002148000A1HS-40 enhancer-containing vector in transgenic animalsFiled 2001·Application pending·0 cites
- 2338US2007196279A1Methods for treating progressive neurodegenerative disordersSHEN CHE-KUN J·Filed 2006·Application pending·0 cites
- 2429US2011177033A1Ras responsive element binding protein 1 (rreb1) as a therapeutic target for thalassemias and sickle cell anemiaACADEMIA SINICA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Che-Kun James Shen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →